ALX ONCOLOGY HOLDINGS INC - 8-K Filing
ALX Oncology entered a $50 million loan agreement with HSBC Ventures USA Inc. on June 25, 2026, including an initial draw of $10 million used to refinance existing debt with Oxford Finance and Silicon Valley Bank. The company also terminated its prior loan agreement dated October 27, 2022. (Items: 1.01 Entry into a Material Definitive Agreement, 1.02 Termination of a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 9.01 Financial Statements and Exhibits)
Tickers: $ALXO